With over 12 million COVID-19 cases and growing, some physicians become ever more open and innovative in their quest to treat their patients. Take Dr. Allen Meglin, practicing in Savannah, Georgia, who now has internalized the need to deal with the frightening next...
Exosomes
Category
What are Next Generation Exosome Therapeutics? A Conversation with Organicell
Back in May, TrialSite reported that Landmark Hospital, a group of long-term acute care hospitals across the southeastern United States, announced its decision to study an investigational allogenic biologic product to test on patients with advanced COVID-19 conditions...
Las Vegas-Based Exosome Rogue Biotech Endangering the Public: FDA Hits with Warning Letter
The U.S. Food and Drug Administration issued a warning letter to EUCYT Laboratories LLC, for first and foremost marketing an unapproved exosome product for the treatment or prevention of COVID-19. There are currently no FDA-approved products to prevent or treat...
First Dosing in Exopharm’s PLEXOVAL Exosome Wound Healing Human Study Down Under
Regenerative medicine company Exopharm Limited (ASX:EX1) announced the first dosing has occurred in the PLEXOVAL Phase I clinical trial using exosomes isolated from human platelets for wound healing. The sponsor expects more participant dosing soon as they seek to...